Peppermint Oil 관련 Irritable Bowel Syndrome (IBS)
AMeta-analyses of 12+ RCTs demonstrate peppermint oil (450-750 mg/day enteric-coated) significantly reduces IBS abdominal pain (RR 1.78 vs placebo). A-grade evidence for global IBS symptom improvement. ACG conditional recommendation.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dpeppermint\u002Doil\u0026condition\u003Dibs';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
결론
Meta-analyses of 12+ RCTs demonstrate peppermint oil (450-750 mg/day enteric-coated) significantly reduces IBS abdominal pain (RR 1.78 vs placebo). A-grade evidence for global IBS symptom improvement. ACG conditional recommendation.
Key Study Findings
Review
Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: patients with IBS (review of plant extracts including peppermint oil, Iberogast, curcumin)
Review
European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management.
Dose: None
vs: None
Outcome: Functional bloating and abdominal distension management
효과: None
None
대상 집단: Patients with functional bloating/distension (consensus)
Review
Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction.
Dose: None
vs: Placebo
Outcome: GI symptoms in DGBI (FD, IBS)
효과: None
None
대상 집단: Patients with functional dyspepsia and IBS (review)
Review
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: Review of herbal remedies for IBS
Review
Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome.
Dose: None
vs: None
Outcome: IBS symptom management
효과: None
None
대상 집단: Patients with IBS (review)
Review
Natural Products for the Treatment of Irritable Bowel Syndrome.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: Patients with irritable bowel syndrome
Key Statistics
19
연구
2569
참여자
↑
Positive
A
등급
Referenced Papers
Nutrients
2026
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical …
Systematic Review
Nutrition reviews
2025
10 인용
Journal of clinical …
2025
8 인용
United European gastroenterology …
2025
5 인용
Digestive and liver …
2025
4 인용
Nutrition in clinical …
2025
3 인용
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
Review
International journal of …
2025
1 인용
Gastroenterology & hepatology
2025
The Medical letter …
2025
Nutrients
2024
5 인용
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Systematic Review
Zeitschrift fur Gastroenterologie
2024
3 인용
BioPsychoSocial medicine
2024
3 인용
Current pharmaceutical design
2023
12 인용
Nutrients
2023
4 인용
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Meta-Analysis
Alimentary pharmacology & …
2022
35 인용
American journal of …
2022
18 인용
Nutrition & dietetics …
2022
12 인용
Neurogastroenterology and motility
2022
11 인용
Alimentary pharmacology & …
2022
1 인용
Alimentary pharmacology & …
2022
Frontline gastroenterology
2021
56 인용
The American journal …
2021
31 인용
The lancet. Gastroenterology …
2020
119 인용
Gastroenterology
2020
96 인용
Nutrition research (New …
2020
42 인용
Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Meta-Analysis
Complementary therapies in …
2020
34 인용
Neurogastroenterology and motility
2020
34 인용
Gastroenterology
2020
8 인용
Journal of the …
2020
1 인용
The Medical letter …
2020
Journal of the …
2019
171 인용
The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data.
Meta-Analysis
BMC complementary and …
2019
167 인용
Current gastroenterology reports
2019
18 인용
World journal of …
2019
14 인용
Alimentary pharmacology & …
2018
148 인용
Nutrients
2018
54 인용
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
Review
British journal of …
2017
145 인용
Journal of gastroenterology …
2017
32 인용
Current opinion in …
2017
24 인용
Current gastroenterology reports
2017
16 인용
Handbook of experimental …
2017
4 인용
American journal of …
2016
15 인용
Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
Meta-Analysis
Journal of clinical …
2014
186 인용
World journal of …
2014
109 인용
Digestion
2014
61 인용
Journal of gastroenterology
2014
47 인용
Voprosy pitaniia
2013
FP essentials
2013
Irritable bowel syndrome.
Systematic Review
BMJ clinical evidence
2012
6 인용
Journal of clinical …
2011
30 인용
Discovery medicine
2011
Therapy options in irritable bowel syndrome.
Meta-Analysis
European journal of …
2010
61 인용
Irritable bowel syndrome.
Systematic Review
BMJ clinical evidence
2010
Canadian family physician …
2009
108 인용
Journal of the …
2009
40 인용
Australian family physician
2009
12 인용
BMJ (Clinical research …
2008
550 인용
Peppermint oil.
Review
American family physician
2007
125 인용
A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.).
Review
Phytotherapy research : …
2006
698 인용
Current treatment options …
2006
24 인용
Peppermint oil.
Review
Pediatrics in review
2006
2 인용
Phytomedicine : international …
2005
72 인용
American family physician
2005
The American journal …
1998
266 인용
The American journal …
1998
13 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 450-750 mg/day enteric-coated capsules
- ibssymptomsupport:
- 187-225 mg enteric-coated capsules, 2-3 times daily, 30-60 min before meals
상한량: Well-tolerated up to 1,200 mg/day in clinical trials; enteric coating essential
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
권장 복용 시간: 30-60 minutes before meals; enteric-coated capsules MUST be swallowed whole (do not chew or crush)
Safety & Side Effects
보고된 부작용
- ⚠ Heartburn/GERD exacerbation (if non-enteric-coated; relaxes lower esophageal sphincter)
- ⚠ Perianal burning sensation (from undigested menthol reaching the rectum)
- ⚠ Nausea at high doses
- ⚠ Allergic reactions in mint-sensitive individuals
알려진 상호작용
- ● Cyclosporine (peppermint may increase cyclosporine levels via CYP3A4 inhibition)
- ● Antacids and PPIs (may dissolve enteric coating prematurely; space 2 hours)
- ● Simethicone (coated formulations may interact with enteric-coated peppermint)
- ● CYP2C19 substrates (menthol is a weak CYP inhibitor)
일일 최대 섭취 허용량: Well-tolerated up to 1,200 mg/day in clinical trials; enteric coating essential
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Peppermint Oil help with Irritable Bowel Syndrome (IBS)?
Based on 19 studies with 2,569 participants, there is strong evidence from multiple clinical trials that Peppermint Oil may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is A (Strong Evidence).
How much Peppermint Oil should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 450-750 mg/day enteric-coated capsules. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Peppermint Oil?
Reported side effects may include Heartburn/GERD exacerbation (if non-enteric-coated; relaxes lower esophageal sphincter), Perianal burning sensation (from undigested menthol reaching the rectum), Nausea at high doses, Allergic reactions in mint-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Peppermint Oil and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 2,569 total participants. The overall direction of effect is positive.
Related Evidence
관련 다른 성분: Irritable Bowel Syndrome (IBS)
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.